Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia

Journal of Infectious Diseases

Volumn 193, Issue 2, 2006, Pages 214-222

  Van Der Sluijs, Koenraad F ^a,d   Nijhuis, Monique ^b   Levels, Johannes H M ^a   Florquin, Sandrine ^a   Mellor, Andrew L ^c   Jansen, Henk M ^a   Van Der Poll, Tom ^a   Lutter, René ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYLTRYPTOPHAN; ENZYME INHIBITOR; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; N METHYLTRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; FEMALE; IMMUNE RESPONSE; INFLAMMATION; INFLUENZA; INFLUENZA VIRUS; INOCULATION; LOBAR PNEUMONIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; SUPERINFECTION;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; DELAYED-ACTION PREPARATIONS; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FEMALE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFLUENZA A VIRUS; INTERLEUKIN-10; LUNG; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE; SURVIVAL ANALYSIS; TRYPTOPHAN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 30944440041     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/498911     Document Type: Article

References (34)

1. Treanor JJ. Orthomyxoviridae: influenza virus. In: Mandell GL, Douglas DR, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 5th ed. New York: Churchill Livingston, 2000:1834-5.
2. Murphy BR, Webster RG. Orthomyxoviruses. In: Fields BN, Knipe DH, Howley PM, eds. Fields virology. 3rd ed. Philadelphia: Lippincott-Raven, 1996:1407.
3. Zhang WJ, Sarawar S, Nguyen P, et al. Lethal synergism between influenza and staphylococcal enterotoxin B in mice. J Immunol 1996; 157:5049-60.
4. Gong JH, Sprenger H, Hinder F, et al. Influenza A virus infection of macrophages: enhanced tumor necrosis factor-α (TNF-α) gene expression and lipopolysaccharide-triggered TNF-α release. J Immunol 1991; 147:3507-13.
5. Le Vine AM, Koenigsknecht V, Stark JM. Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice. J Virol Methods 2001; 94:173-86.
6. Van der Sluijs KF, Van Elden LJR, Nijhuis M, et al. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol 2004; 172:7603-9.
7. Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melen K, Matikainen S. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev 2001; 12:171-80.
8. Kline JN, Fisher PA, Monick MM, Hunninghake GW. Regulation of interleukin-1 receptor antagonist by Th1 and Th2 cytokines. Am J Physiol 1995; 269:L92-8.
9. Konno S, Grindle KA, Lee WM, et al. Interferon-γ enhances rhinovirus-induced RANTES secretion by airway epithelial cells. Am J Respir Cell Mol Biol 2002; 26:594-601.
10. Van Wissen M, Snoek M, Smids B, Jansen HM, Lutter R. IFN-γ amplifies IL-6 and IL-8 responses by airway epithelial-like cells via indoleamine 2,3-dioxygenase. J Immunol 2002; 169:7039-44.
11. Yoshida R, Urade Y, Tokuda M, Hayaishi O. Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection. Proc Natl Acad Sci USA 1979; 76:4084-6.
12. Choi AMK, Knobil K, Otterbein SL, Eastman DA, Jacoby DB. Oxidant stress responses in influenza virus pneumonia: gene expression and transcription factor activation. Am J Physiol 1996; 271:L383-91.
13. Lauw FN, Branger J, Florquin S, et al. IL-18 improves the early antimicrobial host response to pneumococcal pneumonia. J Immunol 2002; 168:372-8.
14. Rijneveld AW, Florquin S, Branger J, Speelman P, van Deventer SJ, van der Poll T. TNF-γ compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia. J Immunol 2001; 167:5240-6.
15. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 1999; 189:1363-72.
16. Munn DH, Zhou M, Attwood JT, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998; 281:1191-3.
17. + dendritic cells. Int Immunol 2002; 14:65-8.
18. Yong S, Lau S. Rapid separation of tryptophan, kynurenines, and indoles using reversed-phase high-performance liquid chromatography. J Chromatogr 1979; 175:343-6.
19. Grohmann U, Fallarino F, Silla S, et al. CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells. J Immunol 2001; 166: 277-83.
20. Von Bubnoff D, Matz H, Frahnert C, et al. FcεRI induces the tryptophan degradation pathway involved in regulating T cell responses. J Immunol 2002; 169:1810-6.
21. Von Bubnoff D, Fimmers R, Bogdanow M, Matz H, Koch S, Bieber T. Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure. Clin Exp Allergy 2004; 34:1056-63.
22. Heikkinen J, Mottonen M, Komi J, Alanen A, Lassila O. Phenotypic characterization of human decidual macrophages. Clin Exp Immunol 2003; 131:498-505.
23. Grant RS, Naif H, Thuruthyil SJ, et al. Induction of indoleamine 2,3-dioxygenase in primary human macrophages by human immunodeficiency virus type 1 is strain dependent. J Virol 2000; 74:4110-5.
24. Dallman MJ, Wood KJ, Hamano K, et al. Cytokines and peripheral tolerance to alloantigen. Immunol Rev 1993; 133:5-18.
25. Groux H, Bigler M, De Vries JE, Roncarolo MG. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 1996; 184:19-29.
26. Dallaire F, Quellet N, Bergeron Y, et al. Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia. J Infect Dis 2001; 184:292-300.
27. Grant RS, Naif H, Thuruthyil SJ, et al. Induction of indoleamine 2,3-dioxygenase in primary human macrophages by HIV-1. Redox Rep 2000; 5:105-7.
28. Munn DH, Sharma MD, Lee JR, et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 2002; 297:1867-70.
29. Curreli S, Romerio F, Mirandola P, Barion P, Bemis K, Zella D. Human primary CD4+ T cells activated in the presence of IFN-α 2b express functional indoleamine 2,3-dioxygenase. J Interferon Cytokine Res 2001; 21:431-7.
30. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A, Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683-765.
31. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein Barr virus gene BCRFI. Science 1990; 248:1230-4.
32. Lutter R, Loman S, Snoek M, Roger T, Out TA, Jansen HM. IL-6 protein production by airway epithelial(-like) cells disabled in IL-6 mRNA degradation. Cytokine 2000; 12:1275-9.
33. Powell MJ, Thompson SA, Tone Y, Waldmann H, Tone M. Posttranscriptional regulation of IL-10 gene expression through sequences in the 3′-untranslated region. J Immunol 2000; 165:292-6.
34. Suzuki S, Tone S, Takikawa O, Kubos T, Kohno I, Minatogawa Y. Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepti. Biochem J 2001; 355:425-9.